Opaleye Management Inc.
· Added
Change
+1.0M
Date
Q1 2026
QT
| Investor | Type | Est. change | Change | Δ Own | Date | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Opaleye Management Inc.
· Added
Change
+1.0M
Date
Q1 2026
|
Opaleye Management Inc. | Added· Q1 2026 | – | +1.0M | – | Q1 2026 | |||||
|
Mackenzie Financial Corp
· New
Change
+246K
Date
Q1 2026
|
Mackenzie Financial Corp | New· Q1 2026 | – | +246K | – | Q1 2026 | |||||
|
Acorn Capital Advisors, LLC
· Reduced
Change
−178K
Date
Q1 2026
|
Acorn Capital Advisors, LLC | Reduced· Q1 2026 | – | −178K | – | Q1 2026 | |||||
|
Pfizer Inc
· Reduced
Change
−176K
Date
Q1 2026
|
Pfizer Inc | Reduced· Q1 2026 | – | −176K | – | Q1 2026 | |||||
|
Monimus Capital Management, LP
· New
Change
+134K
Date
Q1 2026
|
Monimus Capital Management, LP | New· Q1 2026 | – | +134K | – | Q1 2026 | |||||
|
Acadian Asset Management LLC
· Added
Change
+124K
Date
Q1 2026
|
Acadian Asset Management LLC | Added· Q1 2026 | – | +124K | – | Q1 2026 | |||||
|
Renaissance Technologies LLC
· Added
Change
+107K
Δ Own
+107.7%
Date
Q1 2026
|
Renaissance Technologies LLC | Added· Q1 2026 | – | +107K | +107.7% | Q1 2026 | |||||
|
Marshall Wace, LLP
· New
Change
+52K
Date
Q1 2026
|
Marshall Wace, LLP | New· Q1 2026 | – | +52K | – | Q1 2026 | |||||
|
Millennium Management LLC
· Exited
Change
−51K
Δ Own
−100.0%
Date
Q1 2026
|
Millennium Management LLC | Exited· Q1 2026 | – | −51K | −100.0% | Q1 2026 | |||||
|
Monaco Asset Management Sam
· Exited
Change
−51K
Δ Own
−100.0%
Date
Q1 2026
|
Monaco Asset Management Sam | Exited· Q1 2026 | – | −51K | −100.0% | Q1 2026 | |||||
|
Jane Street Group, LLC
· Added
Change
+40K
Date
Q1 2026
|
Jane Street Group, LLC | Added· Q1 2026 | – | +40K | – | Q1 2026 | |||||
|
Vanguard
· Added
Change
+37K
Date
Q1 2026
|
Vanguard | Added· Q1 2026 | – | +37K | – | Q1 2026 | |||||
|
Cambridge Investment Research Advisors, Inc.
· New
Change
+35K
Date
Q1 2026
|
Cambridge Investment Research Advisors, Inc. | New· Q1 2026 | – | +35K | – | Q1 2026 | |||||
|
Citadel Advisors LLC
· Reduced
Change
−30K
Δ Own
−66.1%
Date
Q1 2026
|
Citadel Advisors LLC | Reduced· Q1 2026 | – | −30K | −66.1% | Q1 2026 | |||||
|
BlackRock
· Added
Change
+26K
Date
Q1 2026
|
BlackRock | Added· Q1 2026 | – | +26K | – | Q1 2026 | |||||
| Insider | Title | Type | Price | Qty | Value | Owned | ΔOwn | Trade date | Filed date | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Violette Shelia M.
· Officer
Grant (A)
38K
|
Violette Shelia M. | Officer | Grant (A) | – | 38K | – | 131K | +40.3% | Jul 16, 2026 | Jul 20, 2026 | |||||||||
|
Morrison Jodie Pope
· Director
Grant (A)
132K
|
Morrison Jodie Pope | Director | Grant (A) | – | 132K | – | 353K | +59.7% | Jul 16, 2026 | Jul 20, 2026 | |||||||||
|
Kalowski Lee
· Officer
Grant (A)
53K
|
Kalowski Lee | Officer | Grant (A) | – | 53K | – | 142K | +59.7% | Jul 16, 2026 | Jul 20, 2026 | |||||||||
|
Manke Isaac
· Director
2 operations
0
|
Manke Isaac | Director | 2 operations | $2.80 | 0 | – | 0 | – | Jun 30, 2026 | Jul 2, 2026 | |||||||||
|
Laporte Kathleen
· Director
Grant (A)
10K
|
Laporte Kathleen | Director | Grant (A) | – | 10K | – | 10K | – | Jun 12, 2026 | Jun 16, 2026 | |||||||||
|
Iwicki Mark T.
· Director
Grant (A)
10K
|
Iwicki Mark T. | Director | Grant (A) | – | 10K | – | 10K | – | Jun 12, 2026 | Jun 16, 2026 | |||||||||
|
Manke Isaac
· Director
Grant (A)
10K
|
Manke Isaac | Director | Grant (A) | – | 10K | – | 10K | – | Jun 12, 2026 | Jun 16, 2026 | |||||||||
|
Tzianabos Arthur
· Director
Grant (A)
10K
|
Tzianabos Arthur | Director | Grant (A) | – | 10K | – | 10K | – | Jun 12, 2026 | Jun 16, 2026 | |||||||||
|
Grayzel David S.
· Director
Grant (A)
10K
|
Grayzel David S. | Director | Grant (A) | – | 10K | – | 10K | – | Jun 12, 2026 | Jun 16, 2026 | |||||||||
|
Thistle Mary
· Director
Grant (A)
10K
|
Thistle Mary | Director | Grant (A) | – | 10K | – | 10K | – | Jun 12, 2026 | Jun 16, 2026 | |||||||||
|
Xu Diyong
· Director
Grant (A)
10K
|
Xu Diyong | Director | Grant (A) | – | 10K | – | 10K | – | Jun 12, 2026 | Jun 16, 2026 | |||||||||
|
Lundberg Sven Ante
· Director
Grant (A)
10K
|
Lundberg Sven Ante | Director | Grant (A) | – | 10K | – | 10K | – | Jun 12, 2026 | Jun 16, 2026 | |||||||||
|
Xu Diyong
· Director
2 operations
+$15M
|
Xu Diyong | Director | 2 operations | $8.00 | +1.9M | +$15M | 625K | – | May 28, 2026 | Jun 1, 2026 | |||||||||
|
Orbimed Advisors LLC
· Director
2 operations
+$15M
|
Orbimed Advisors LLC | Director | 2 operations | $8.00 | +1.9M | +$15M | 625K | – | May 28, 2026 | Jun 1, 2026 | |||||||||
|
Kalowski Lee
· Officer
Sell
−$18K
|
Kalowski Lee | Officer | Sell | $4.51 | −4K | −$18K | 36K | – | Feb 25, 2026 | Feb 27, 2026 | |||||||||
N
M
A
A
T
U
40 reporting institutions disclosed QTTB position changes in the Q1 2026 snapshot.
For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.
An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.
Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.
Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.
A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.